[1] Reed CE.Surgical management of esophageal carcinoma[J].Oncologist,1999,4(2):95-105.
[2] 万均,肖爱幼,高淑珍,等.食管癌放疗后近期疗效评价标准--附1 000例分析[J].中国放射肿瘤学,1989,3(4):205-207.
[3] 周际昌.抗肿瘤药的不良反应及处理
[M]//周际昌.实用肿瘤内科学.北京:人民卫生出版社,1998:205-297.
[4] Cox JD,Stetz J,Pajak TF.Toxicity criteria of the Radiation Therapy Oncology Group(RTOG) and the European Organization for Research and Treatment of Cancer(EORTC)[J].Int J Radiat Oncol Biol Phys,1995,31(5):1341-1346.
[5] Cooper JS,Guo MU,Herskovic A,et al.Chemoradiotherapy of locally advanced esophageal cancer:long-term follow-up of a prospective randomized trial(RTOG 85-01):Radiation Therapy Oncology Group[J].JAMA,1999,281(17):1623-1627.
[6] Minsky BD,Pajak T,Ginsberg RJ,et al.INT 0123(RTOG 9405)phase Ⅲ trial of combined modality therapy for esophageal cancer:high dose(64.8 Gy)vs.standard dose(50.4 Gy)radiation therapy[J].Clin Oncol,2002,20(5):1167-1174.
[7] 蔺强,高献书,乔学英,等.食管癌患者同期放化疗顺铂加氟尿嘧啶方案Ⅱ期临床试验[J].癌症,2008,27(10):1077-1081.
[8] 王澜,韩春,李晓宁,等.中晚期食管癌三维适形放疗联合同期化疗的临床观察[J].中华肿瘤防治杂志,2010,17(24):2053-2056.
[9] 刘俊,吕长兴,王家明.同步放化疗治疗不能手术的食管癌临床结果[J].中华放射肿瘤学杂志,2006,15(3):185-187.
[10] 王新强,程秀祯,王世伟,等.放疗联合PF方案同期治疗中晚期食管癌[J].中华放射肿瘤学杂志,2005,14(3):215.
[11] 李晓敏,王玉,戴建平,等.食管癌后程加速超分割放射治疗协同化疗的临床研究[J].中华放射肿瘤学杂志,2003,12(1):1-3.
[12] 张好,俞明根,钱荣誉,等.食管癌后程加速超分割放疗协同化疗的疗效评价[J].中华放射肿瘤学杂志,2006,15(2):89-92.
[13] 王澜,王军,韩春,等.食管癌同期放化疗的价值研究[J].中华放射肿瘤学杂志,2011,20(4):291-295.
[14] 陈尔成,刘孟忠,胡永红,等.不能手术切除行同期放化疗的食管癌患者预后的多因素分析[J].癌症,2005,24(6):731-734.
[15] 中国非手术治疗食管癌临床分期专家小组.非手术治疗食管癌临床分期标准[J].中华放射肿瘤学杂志,2010,19(3):179-180.
[16] 王玉祥,祝淑钗,邱嵘,等.三维适形放疗治疗T4期食管癌预后分析[J].肿瘤防治研究,2011,38(6):690-694.
[17] Shimada H,Shiratori T,Takeda A,et al.Perioperative changes of serum p53 antibody titer is a predictor for survival in patients with esophageal squamous cell carcinoma[J].World J Surg,2009,33(2):272-277.